Delivery Order SPE2DB20D3103-SPE2DB23FP6V2
Award Date
9/11/23
Potential Completion Date
9/12/23
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,857.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROLENSA 0.07% eye drops, a pharmaceutical product, and has a completion date of November 7, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated with any set-aside requirements, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,258,236 units of PROLENSA 0.07% eye drops. The Firm Fixed Price delivery order, valued at $4,319.98, has a period of performance through March 15, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of PROLENSA 0.07% eye drops (3ml) to the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on September 26, 2023, with a total ceiling value of $19,398.20 and a completion date of September 27, 2023. The contract is a delivery order with a firm fixed-price pricing type. This contract is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $2,148.47 firm fixed-price delivery order is for the supply of PROLENSA 0.07% eye drops. The contract has an ultimate completion date of January 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award is for the delivery of PROLENSA 0.07% eye drops in a 3mL size, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $31,080.95, was issued by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense (DoD) and Department of Veterans...
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,555,355,594 units of PROLENSA 0.07% eye drops in 3 milliliter vials. The firm-fixed-price delivery order, valued at $16,328.27, has a period of performance through November 9, 2021. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,564.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROLENSA 0.07% eye drops with an ultimate completion date of January 28, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery...
This federal contract award, with an ID of SPE2DX15D2100|SPE2DX24F33WM, was granted to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The $21,758.06 Firm Fixed Price Delivery Order contract is for the supply of PROLENSA 0.07% eye drops to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of January 19, 2024 and was awarded on January 18, 2024. This award is not associated with a set-aside program....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROLENSA 0.07% eye drops, a prescription medication, with a ceiling value of $1,241.13 and a completion date of December 14, 2023. This is a Firm Fixed Price (FFP) Delivery Order contract, which indicates it is part of a larger Indefinite Delivery Contract (IDC) vehicle with the DLA....
This federal contract award, valued at $7,455.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560410185 PROLENSA 0.07% eye drops, a specialty pharmaceutical product, with a period of performance through March 29, 2023. This delivery order is under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...